Camposol Holding Ltd.'s Invitation to the Presentation of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Camposol Holding Ltd.'s Invitation to the Presentation of Second Quarter 2016 Financial Results

LIMA, Peru, Aug. 9, 2016 (GLOBE NEWSWIRE) -- Camposol Holding Ltd. will hold a conference call announcing the second quarter 2016 results on Thursday August 18, 2016. The telephone conference will be held at 10:00 a.m. (Lima) as described below.

Manuel Salazar, CEO, and Maria Cristina Couturier, CFO, will host the conference call presentation and a Q&A session at 10:00 a.m. (Lima).

To participate in the conference call, please use the following numbers:

London, UK Local                                        +44 (0) 20 3427 1914

New York, US Local                                     +1 646 254 3360

Oslo, Norway, Local                                     +47 2316 2729

Colombia National Free Phone                      01 800 915 7431

Participants will be asked for their name and conference ID.

The Camposol conference ID is: 4460137

Audio access for the meeting is available by dialing the above mentioned numbers.

To access the presentation webcast in connection with the conference call, please use:

http://edge.media-server.com/m/p/tb9wbge8

Participants are advised to log on to the service and check their configuration well ahead of the telephone conference commencement.

Please use the following link (that is also available from the registration page of your webcasts):  http://edge.media-server.com/m/player/help/sy...php?lan=en   

If you are unable to participate in the call, a playback of the conference is available until August 26, 2016 by dialing:

Replay - London, UK Local                           +44 (0) 20 3427 0598

Replay - US Local                                       +1 347 366 9565

Replay - Oslo, Norway Local                        +47 2100 0498

Followed by replay access number: 4460137

For further information, please contact:

Jossue Yesquen Lihim, Head of IR jyesquen@camposol.com.pe Phone: +511 621 0800 - Ext: 7171

About CAMPOSOL

CAMPOSOL is the leading agro industrial company in Peru, the first producer of avocados and soon the first producer of blueberries in the world. It is involved in the harvest, processing and marketing of high quality agricultural products such as avocados, asparagus, blueberries, grapes, mangoes, tangerines and shrimp; which are exported to Europe, the United States of America and Asia.

CAMPOSOL is a vertically integrated company located in Peru, offering fresh and frozen products. It is the third largest private employer of the country, with more than 13 thousand workers in high season, and is committed to support sustainable development through social responsibility policies and projects aimed to increase the shared-value for all of its stakeholders.

CAMPOSOL was the first Peruvian agro industrial company to present annual audited sustainability reports. CAMPOSOL has achieved the following international certifications: BSCI, Global Gap, IFS, HACCP and BRC among others.

To learn more about CAMPOSOL please visit:   www.camposol.com.pe   

HUG#2034119

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 49

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 0

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 114

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 109

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 252

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 102

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 34

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 203

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

Shareholder Alert: Join the Class Action for Synopsys, Inc.

Updated Category News Views 142

Important Information for Synopsys, Inc. Shareholders As a shareholder of Synopsys, Inc. (NASDAQ: SNPS), you are encouraged to join a class action lawsuit that aims to address significant concerns raised about the company. Recent allegations indicate that misleading statements and non-disclosed information have adversely affected shareholder investments. The Gross Law...

Continue Reading
Strategic Leadership Changes at Fidelity National Unveiled

Updated Category News Views 772

Fidelity National Information Services Appoints New Chief People Officer Fidelity National Information Services, Inc. (NYSE:FIS) has announced that Robert Toohey will take on the role of Corporate Executive Vice President and Chief People Officer starting January 1, 2025. L. Denise Williams, the current Chief People Officer, will continue in her position until December...

Continue Reading
Exploring the Potential of Australia's Superannuation for US Workers

Updated Category News Views 172

Trump's Intentions for Retirement Savings Reform Recent discussions have unveiled that President Donald Trump is genuinely contemplating the introduction of a retirement savings framework in the U.S. that's reminiscent of Australia’s successful system. This revelation could herald significant changes to how Americans approach their retirement savings. Insights from...

Continue Reading
GCC S.A.B. de C.V. Announces Q2 2025 Financial Performance

Updated Category News Views 210

GCC S.A.B. de C.V. Achieves Notable Sales Growth in Q2 2025 GCC, S.A.B. de C.V. (BMV: GCC*), a prominent player in the cement, aggregates, and concrete markets across the United States and Mexico, reported its financial outcomes for the second quarter of 2025, highlighting a mixture of growth in sales and pressures on profitability. Quarterly Financial Highlights This...

Continue Reading
Silo Pharma’s Groundbreaking SPC-15 Study Marks New Chapter

Updated Category News Views 210

Advancing Towards Clinical Trials: Silo Pharma's SPC-15 Silo Pharma, Inc. (NASDAQ: SILO), a pioneering biopharmaceutical firm, has recently undertaken significant steps to advance its promising drug candidate, SPC-15, through essential safety studies. Collaborative efforts with Frontage Laboratories signify a vital phase in developing innovative solutions for...

Continue Reading